The first ten weeks were intervention. Everything after is signal architecture. The mistake most men make on TRT is treating "maintenance" as "keep injecting and forget." That's how you end up at month 18 with crashed estradiol, atrophied testicles, suppressed pituitary, hematocrit climbing past 54%, and a fasting insulin that quietly rotted your GH response. Maintenance is not a lower-effort version of the protocol. It's a different protocol — one engineered for receptor preservation, axis durability, and decade-scale tissue quality.
What's actually happening in the maintenance phase
Continuous exogenous testosterone shuts down GnRH pulsatility. LH and FSH drop to functionally zero. Without LH, the Leydig cells stop producing intratesticular testosterone — which sits at concentrations roughly 100x serum levels and is required for spermatogenesis. Sertoli cells lose their FSH signal. Testicular volume drops. Pregnenolone and DHEA production downstream of the testes falls off. None of this is fixed by adding more testosterone. The substrate is explicit on this point: exogenous T alone suppresses the intratesticular environment that exogenous T cannot replace.
The maintenance stack solves this by running a parallel signal. HCG mimics LH at the Leydig cell receptor, restoring intratesticular testosterone, testicular volume, and the neurosteroid cascade (pregnenolone, DHEA) that nothing else on the protocol replaces. Gonadorelin pulses GnRH upstream — more physiologic than HCG but shorter half-life. Kisspeptin-10 acts even further upstream at the GnRH neuron and is the most physiologic option, though the practitioner corpus is thinner here and labels it experimental for sustained HPG maintenance during TRT.
Receptor biology drives the rest of the maintenance design. The substrate is unambiguous: continuous GHRH stimulation downregulates the pituitary GH receptor. Constant signal means the receptor stops listening. This is why CJC-1295 and ipamorelin must be cycled — not optional, not a stylistic choice. Same logic applies to anastrozole (crash estradiol and you lose libido, joint integrity, bone density, mood) and to any compound running through a receptor that adapts to chronic occupancy. Maintenance is hormesis: pulse, recover, pulse again.
The maintenance protocol
| Compound | Dose | Route | Frequency | Evidence Tier | Notes |
|---|---|---|---|---|---|
| Testosterone (TRT base) | Dose-titrated to free T mid-upper reference | IM or SubQ | 2x/week (split) | Clinical 🔵 | Split dosing stabilizes E2 and minimizes peak-trough swings |
| HCG | 250–500 IU | SubQ | On TRT injection days (or EOD) | Clinical 🔵 | Preserves testicular volume, intratesticular T, fertility, pregnenolone/DHEA cascade |
| Gonadorelin | 200 mcg | SubQ | Daily or every other day | Expert 🟢 | Alternative to HCG when more physiologic pulsatile stimulation preferred |
| Kisspeptin-10 | 50–100 mcg | SubQ | Daily | Experimental 🟣 | Upstream GnRH stimulator. Use case: fertility preservation when HCG response is blunted |
| Anastrozole | 0.25–0.5 mg | Oral | 2x/week — titrate to E2 | Clinical 🔵 | Only if E2 is symptomatically elevated on sensitive assay. Do not chase a number |
| Pregnenolone | 25–50 mg | Oral | Daily (AM) | Expert 🟢 | "Mother hormone" — replaces what suppressed Leydig output stops making |
| CJC-1295 (no DAC) + Ipamorelin | 100 mcg / 200 mcg | SubQ | 5 nights on, 2 off — 8 weeks on, 4 weeks off | Expert 🟢 | Pulsatile GH support. Cycling mandatory — receptor downregulates on continuous stimulation |
| TB-500 (maintenance) | 2.5 mg | SubQ | Every 7–10 days | Expert 🟢 | Cardiovascular, flexibility, systemic tissue quality. Sustainable indefinitely at this dose |
| Thymosin Alpha-1 | 1.6 mg | SubQ | 2x/week | Expert 🟢 | Immune ceiling rises decade by decade — TA-1 becomes more valuable, not less |
| Epithalon | 10 mg | SubQ | 3x/week for 3 weeks, once or twice yearly | Experimental 🟣 | Pulsed longevity stack. Telomere-protective in long-follow-up human data |
The lab cadence that actually matters
Quarterly is the default. Annually is too coarse — drift accumulates. Monthly is overkill outside the first six months and creates noise-chasing. Every 90 days, pull: total testosterone, free testosterone, SHBG, estradiol (sensitive/LC-MS assay — not the standard immunoassay), LH, FSH, hematocrit, hemoglobin, ferritin, fasting insulin, HbA1c, IGF-1, comprehensive metabolic panel, and lipids. If fertility is a live goal: semen analysis every 6 months.
LH and FSH should not be zero if the HCG or gonadorelin layer is doing its job upstream-protective work. Estradiol should be in range, not crushed. Hematocrit climbing past 52–54% is a flag — donate blood before adjusting the testosterone dose. Fasting insulin above 8 blunts GH secretagogue response; fix the insulin before blaming the peptide.
The lifestyle layer that runs underneath all of it
The substrate is consistent: resistance training is not adjunct. It's load-bearing. Compound lifts with lower-body inclusion (deadlifts, squats, pull-ups paired with upper-body work) produce significantly higher testosterone response than upper-body-only training. Combined resistance and aerobic work drives a roughly 50% improvement in erectile function on top of the hormonal lift. Sleep is the second axis — same time every night, morning sunlight, no blue light after sundown. Without sleep architecture, you are subsidizing pharmacology against a circadian deficit.
What you should feel in a well-tuned maintenance phase
- Month 1: Stable energy across the day, no afternoon trough. Morning erections preserved. Recovery between training sessions noticeably faster than pre-TRT.
- Month 3: First quarterly labs land in target. Testicular volume restored on HCG/gonadorelin (visible and measurable). Libido stable, not fluctuating with injection timing.
- Month 6: Body composition continues to drift favorably without dose changes. GH cycle window produces visible recovery and sleep depth improvements on the on-weeks.
- Year 1+: Subjective metrics flatten — you stop noticing testosterone because it stopped being a variable. This is the signal that the protocol is working.
What's NOT happening — false expectations to retire
- Maintenance is not a permission slip to skip labs. Quarterly is non-negotiable. Hematocrit and E2 drift silently.
- Adding more compounds does not improve a stable protocol. Stack discipline is the second-decade superpower.
- HCG does not "restart" the system if you stop TRT. It maintains testicular function while suppressed. PCT is a different protocol.
- Anastrozole is not prophylactic. Take it only when E2 is symptomatically high on a sensitive assay. Crashed estrogen costs you joints, libido, mood, and bone density.
- The GH cycle is not "year-round at low dose." Continuous GHRH stimulation kills the receptor. The off-weeks are the protocol, not a break from it.
- Resistance training is not optional volume. The exogenous testosterone is amplified by the muscular demand signal. Without the training, you are paying for hormones you cannot fully use.
Practitioner consensus describes this maintenance shape. Pull labs, track the trend, adjust the lever closest to the signal.